The Impact of Peripheral Blood Stem Cell Transplants (PBSCT) on Platelet Usage

By Evely R.S.   Wood R.B.   Burnett A.K.  

Transfusion Science, Vol. 18, Iss. 1, 1997-03 ,pp. : 139-146

Elsevier

Access to resources Recommend Favorite

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

By Ilhan O.   Arslan O.   Arat M.   Beksac M.   Akan H.   Ozcan M.   Gurman G.   Konuk N.   Uysal A.   Koc H.  

Transfusion and Apheresis Science, Vol. 20, Iss. 1, 1999-02 ,pp. : 69-71

Elsevier

Access to resources Recommend Favorite

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

By Ilhan O.   Arslan O.   Arat M.   Beksac M.   Akan H.   Ozcan M.   Gurman G.   Konuk N.   Uysal A.   Koc H.  

Transfusion Science, Vol. 20, Iss. 1, 1999-02 ,pp. : 69-71

Elsevier

Access to resources Recommend Favorite

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

By Glossmann J.-P.   Josting A.   Pfistner B.   Paulus U.   Engert A.  

Annals of Hematology, Vol. 81, Iss. 8, 2002-08 ,pp. : 424-429

Springer Publishing Company

Access to resources Recommend Favorite

Platelet Loss During Peripheral Blood Progenitor Cell Collections

By McCarthy L.J.   Danielson C.   Orazi A.   Skipworth E.   Jackson L.   Graves V.   Gharpure V.   Cornetta K.  

Transfusion and Apheresis Science, Vol. 17, Iss. 3, 1996-09 ,pp. : 475-475

Elsevier

Access to resources Recommend Favorite